SPIRITT is a patient-centric evidence development and specialty clinical research organization, founded in 2012 in the United States. It is focused on delivering high-quality patient-informed evidence in the medical device, biologic, and pharmaceutical industries. The company offers management services for medical practices and industry sponsors, including clinical study development and execution services, regulatory guidance, product development, and educational training/support services.
The goal of SPIRITT is to collect evidence that will improve healthcare outcomes for patients, healthcare providers, and medical technology companies. With the implementation of the Patient Protection and Affordable Care Act in the United States, evidence collection and successful patient outcomes are becoming increasingly important. SPIRITT is well-positioned to assist its clients with developing and implementing a strategy to collect and report validated evidence across diverse therapeutic areas, which will enable the traceability of healthcare outcomes.
SPIRITT offers the experience and expertise to manage any aspect of a project with total confidentiality and strict adherence to regulatory guidelines and Good Clinical Practices. While the last known investment and investors are not specified, the company operates in the Education and Health Care industries, presenting an innovative approach to evidence development and clinical research within the healthcare sector.